Key result
Synchronized electrical cardioversion achieved a 96.0% success rate in converting paroxysmal atrial fibrillation to sinus rhythm, significantly outperforming both amiodarone (81.2%) and propafenone (78.8%).
Why the study?
Atrial fibrillation is a pervasive global health concern contributing significantly to stroke, heart failure, sudden death, and cardiovascular morbidity.
Does amiodarone, propafenone, or electrical cardioversion improve conversion to sinus rhythm in patients with paroxysmal atrial fibrillation?
Observational (n=127)
No
Does amiodarone, propafenone, or electrical cardioversion improve conversion to sinus rhythm in patients with paroxysmal atrial fibrillation?
Synchronized electrical cardioversion is highly effective for converting paroxysmal atrial fibrillation to sinus rhythm, while propafenone acts faster for episodes under 8 hours and amiodarone is more effective for episodes over 24 hours.
May favor synchronized cardioversion for paroxysmal AF; leaves open definitive superiority pending randomized trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mihails Tracevskis (2023) conducted an observational in Paroxysmal atrial fibrillation (n=127). Synchronized electrical cardioversion vs. Amiodarone or propafenone was evaluated on Conversion of atrial fibrillation paroxysm to sinus rhythm (p=<0.001). Synchronized electrical cardioversion achieved a 96.0% success rate in converting paroxysmal atrial fibrillation to sinus rhythm, significantly outperforming both amiodarone (81.2%) and propafenone (78.8%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: